Eton Pharmaceuticals, Inc. ETON D&A

D&A at other companies

HRO

HarrowHROW

$460K-7.3%

XER

Xeris Biopharma Holdings, Inc.XERS

$323K-0.6%

ANI PharmaceuticalsANIP

$19.64M-15.6%

Zevra Therapeutics, Inc.ZVRA

$364K-78.0%

Ultragenyx PharmaceuticalRARE

$8M-11.1%

Rigel PharmaceuticalsRIGL

$597K-1.2%

FAQ

What is Eton Pharmaceuticals, Inc.'s D&A?

Eton Pharmaceuticals, Inc. (ETON) reported D&A of $1.13M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s D&A changed year-over-year?

Eton Pharmaceuticals, Inc.'s D&A increased by 11.6% year-over-year, from $1.01M to $1.13M.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s D&A?

Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s D&A has grown at a 72.0% compound annual growth rate (CAGR), from $462K to $4.04M.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.